Berraondo P, Nouzé C, Préville X, Ladant D, Leclerc C (2007). Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system. Cancer Res. 67:8847-55.

Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F et al (2009). A review of human carcinogens--Part B: biological agents. Lancet Oncol; 10: 321-2.

Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, IARC Monograph Working Group (2005). Carcinogenicity of human papillomaviruses. Lancet Oncol; 6: 204.

Dadaglio G, Morel S, Bauche C, Moukrim Z, Lemonnier FA, Van Den Eynde BJ, Ladant D, Leclerc C (2003). Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes. Int Immunol. 15:1423-30.

Fayolle, C., Sebo, P., Ladant, D., Ullmann, A., and Leclerc, C. (1996). In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes. J Immunol 156, 4697-4706.

Guermonprez, P., Ladant, D., Karimova, G., Ullmann, A., and Leclerc, C. (1999). Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway. J Immunol 162, 1910-1916.

Guermonprez P, Khelef N, Blouin E, Rieu P, Ricciardi-Castagnoli P, Guiso N, Ladant D, Leclerc C (2001). The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). J Exp Med. 193:1035-44.

Guermonprez, P., Fayolle, C., Rojas, M.J., Rescigno, M., Ladant, D., and Leclerc, C. (2002). In vivo receptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11c + CD8 alpha -CD11bhigh dendritic cells. Eur J Immunol 32, 3071-3081.

Hervas-Stubbs S, Majlessi L, Simsova M, Morova J, Rojas MJ, Nouzé C, Brodin P, Sebo P, Leclerc C (2006). High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection. Infect Immun. 74:3396-407.

Heng B, Glenn WK, Ye Y, Tran B, Delprado W, Lutze-Mann L et al (2009). Human papilloma virus is associated with breast cancer. Br J Cancer; 101:1345-50.

IARC Monograph Working Group, zur Hausen H, Arbyn M, Villa L, Franco EL, et al. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (2007). Vol 90: Human Papillomaviruses. Cogliano V, Baan R, Straif K, et al, editors. Lyon: IARCPress,. pp. 1-670.

Loucka, J., Schlecht, G., Vodolanova, J., Leclerc, C., and Sebo, P. (2002). Delivery of a MalE CD4(+)-T-cell epitope into the major histocompatibility complex class II antigen presentation pathway by Bordetella pertussis adenylate cyclase. Infect Immun 70, 1002-1005.

Majlessi L, Simsova M, Jarvis Z, Brodin P, Rojas MJ, Bauche C, Nouzé C, Ladant D, Cole ST, Sebo P, Leclerc C (2006). An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis. Infect Immun.74(4):2128-37.

Mascarell L, Fayolle C, Bauche C, Ladant D, Leclerc C (2005). Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis. J Virol. 79:9872-84.

Mascarell L, Bauche C, Fayolle C, Diop OM, Dupuy M, Nougarede N, Perraut R, Ladant D, Leclerc C (2006). Delivery of the HIV-1 Tat protein to dendritic cells by the CyaA vector induces specific Th1 responses and high affinity neutralizing antibodies in non human primates. Vaccine. 24:3490-9.

Preville, X., Ladant, D., Timmerman, B., and Leclerc, C. (2005). Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein. Cancer Res 65, 641-649.

Saron MF, Fayolle C, Sebo P, Ladant D, Ullmann A, Leclerc C (1997). Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus. Proc Natl Acad Sci U S A 94:3314-9.

Schlecht G, Loucka J, Najar H, Sebo P, Leclerc C (2004). Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming. J Immunol. 173:6089-97.